Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing J Li, L Wang, H Mamon, MH Kulke, R Berbeco, GM Makrigiorgos Nature medicine 14 (5), 579-584, 2008 | 504 | 2008 |
Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis S Ogino, T Kawasaki, M Brahmandam, M Cantor, GJ Kirkner, ... The Journal of molecular diagnostics 8 (2), 209-217, 2006 | 450 | 2006 |
Somatic mutations drive distinct imaging phenotypes in lung cancer E Rios Velazquez, C Parmar, Y Liu, TP Coroller, G Cruz, O Stringfield, ... Cancer research 77 (14), 3922-3930, 2017 | 371 | 2017 |
Noninvasive detection of EGFR T790M in gefitinib or erlotinib resistant non–small cell lung cancer Y Kuang, A Rogers, BY Yeap, L Wang, M Makrigiorgos, K Vetrand, ... Clinical Cancer Research 15 (8), 2630-2636, 2009 | 276 | 2009 |
Bystander effect produced by radiolabeled tumor cells in vivo LY Xue, NJ Butler, GM Makrigiorgos, SJ Adelstein, AI Kassis Proceedings of the National Academy of Sciences 99 (21), 13765-13770, 2002 | 251 | 2002 |
PCR-based methods for the enrichment of minority alleles and mutations CA Milbury, J Li, GM Makrigiorgos Clinical chemistry 55 (4), 632-640, 2009 | 199 | 2009 |
Targeted radiotherapy with gold nanoparticles: current status and future perspectives W Ngwa, R Kumar, S Sridhar, H Korideck, P Zygmanski, RA Cormack, ... Nanomedicine 9 (7), 1063-1082, 2014 | 198 | 2014 |
Localized dose enhancement to tumor blood vessel endothelial cells via megavoltage X-rays and targeted gold nanoparticles: new potential for external beam radiotherapy RI Berbeco, W Ngwa, GM Makrigiorgos International Journal of Radiation Oncology* Biology* Physics 81 (1), 270-276, 2011 | 172 | 2011 |
Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer GS Herter-Sprie, S Koyama, H Korideck, J Hai, J Deng, YY Li, ... JCI insight 1 (9), 2016 | 162 | 2016 |
Nanoparticle mediated tumor vascular disruption: a novel strategy in radiation therapy S Kunjachan, A Detappe, R Kumar, T Ireland, L Cameron, DE Biancur, ... Nano letters 15 (11), 7488-7496, 2015 | 162 | 2015 |
DNA amplification method tolerant to sample degradation G Wang, E Maher, C Brennan, L Chin, C Leo, M Kaur, P Zhu, M Rook, ... Genome research 14 (11), 2357-2366, 2004 | 131 | 2004 |
In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds W Ngwa, H Korideck, AI Kassis, R Kumar, S Sridhar, GM Makrigiorgos, ... Nanomedicine: Nanotechnology, Biology and Medicine 9 (1), 25-27, 2013 | 125 | 2013 |
Radiotoxicity of in V79 Cells: A Comparison with GM Makrigiorgos, AI Kassis, J Baranowska-Kortylewicz, KD McElvany, ... Radiation research 118 (3), 532-544, 1989 | 122 | 1989 |
Ice -COLD-PCR enables rapid amplification and robust enrichment for low-abundance unknown DNA mutations CA Milbury, J Li, GM Makrigiorgos Nucleic acids research 39 (1), e2-e2, 2011 | 121 | 2011 |
DNA damage enhancement from gold nanoparticles for clinical MV photon beams RI Berbeco, H Korideck, W Ngwa, R Kumar, J Patel, S Sridhar, S Johnson, ... Radiation research 178 (6), 604-608, 2012 | 115 | 2012 |
Advanced multimodal nanoparticles delay tumor progression with clinical radiation therapy A Detappe, S Kunjachan, L Sancey, V Motto-Ros, D Biancur, P Drane, ... Journal of Controlled Release 238, 103-113, 2016 | 104 | 2016 |
Limitations of conventional internal dosimetry at the cellular level GM Makrigiorgos, SJ Adelstein, AI Kassis Journal of nuclear medicine 30 (11), 1856-1864, 1989 | 103 | 1989 |
COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing J Li, GM Makrigiorgos Biochemical Society Transactions 37 (2), 427-432, 2009 | 100 | 2009 |
A PCR-based amplification method retaining the quantitative difference between two complex genomes GM Makrigiorgos, S Chakrabarti, Y Zhang, M Kaur, BD Price Nature biotechnology 20 (9), 936-939, 2002 | 96 | 2002 |
Third generation gold nanoplatform optimized for radiation therapy R Kumar, H Korideck, W Ngwa, RI Berbeco, GM Makrigiorgos, S Sridhar Translational cancer research 2 (4), 2013 | 94 | 2013 |